Advertisements



Nektar reports 48% overall response rate in urothelial cancer for NKTR-214 combo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 12th, 2019

Nektar bladder cancer response rate exceeded expectation, says Mizuho

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 12th, 2019

Iovance reports 27% objective response rate in study of cervical carcinoma

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Iovance reports objective response rate of 37% in Cohort 2 of C-144-01 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Nektar Plummets Amid Concern Over Cancer-Drug Trial Results

Nektar Therapeutics lost a third of its value in Monday trading after response rates in melanoma and kidney cancer patients decreased in a mid-stage trial of the company’s cancer drug in combination with Bristol-Myers Squibb Co.’s Opdivo......»»

Category: topSource: moneycentralJun 4th, 2018

We just got a lot of updates on the state of cancer treatments — here are the winners and losers (BLUE, NKTR, LOXO, MRK, BMY)

Over the weekend at the American Society of Clinical Oncologists meeting, a lot of updates and new data were presented.  It sent stocks all over the place Monday with the biggest movers being Bristol-Myers Squibb, Nektar, Loxo and Bluebird bi.....»»

Category: topSource: businessinsiderJun 4th, 2018

Why Nektar Therapeutics Shares Are Tumbling

Nektar Therapeutics (NASDAQ: NKTR) saw its shares get nearly halved in Monday’s session after the company released preliminary data from its early stage cancer study. The preliminary results........»»

Category: blogSource: 247wallstJun 4th, 2018

Dynavax abstract shows 40% response rate in head and neck cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2018

Nektar Starts Phase I/II Combo for Advanced Solid Tumors

Nektar (NKTR) initiates dosing in a phase I/II study, evaluating the combination of its two novel immuno-oncology agent.....»»

Category: worldSource: nytApr 12th, 2018

Nektar says PIVOT-2 study data demonstrated "important response rates"

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 15th, 2019

American Express reports January net write-off rate 2.2% vs. 2.2% prior month

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 15th, 2019

Bank of America reports January default rate 2.65% vs. 2.63% last month

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 15th, 2019

Synchrony reports January charge-off rate 4.72% vs. 4.86% last month

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 15th, 2019

TYME Reports Third Quarter Fiscal 2019 Financial and Operating Results

TYME's novel metabolic-based investigational cancer therapy, SM-88, demonst.....»»

Category: earningsSource: benzingaFeb 11th, 2019

Data Supports One Nation MP Charles Smith, Labor is Ignoring Crime Wave

The war of words continues between One Nation MP Charles Smith and the Minister for Police, Michelle Roberts, as Mr Smith accuses her latest response towards Maddington’s increasing crime rate as fostering a culture of arrogance and.....»»

Category: topSource: livetradingnewsFeb 11th, 2019

Euro zone business growth almost stalled in Jan - PMI

Euro zone businesses started the year by expanding at their weakest rate since mid-2013 as a manufacturing slowdown spread to services, according to the final PMI readings for January. David Pollard reports......»»

Category: videoSource: reutersFeb 5th, 2019

Negative Rates Would Have Sped Up Economic Recovery, Fed Paper Says

The Federal Reserve never played the negative interest rate card in response to the financial crisis, but new research claims the economy probably would have recovered faster if it had......»»

Category: smallbizSource: wsjFeb 5th, 2019

U.S. job growth surges in January

U.S. employers hired the most workers in 11 months in January, adding 304,000 jobs. The unemployment rate ticked up to 4 percent. Fred Katayama reports......»»

Category: videoSource: reutersFeb 1st, 2019

Fed will be "patient" on U.S. rate hikes

The U.S. Federal Reserve held interest rates steady and vowed to be patient in further lifting borrowing costs. Fred Katayama reports......»»

Category: videoSource: reutersJan 30th, 2019

Pfizer seeks new round of growth by treating cancer, WSJ reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 28th, 2019

Brainstorm Health: WHO on Cancer Drug Prices, Growing Uninsurance Rate, Migraine Drug Wars

Brainstorm Health Dail.....»»

Category: europeSource: fortuneJan 25th, 2019